Simos Simeonidis

Insider Reports History

Location
Greenwich, CT
Signature
Christopher Aker, Attorney in Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Simos Simeonidis:

Company Role Class Num Shares Value Price $ Report Date Ownership
Regulus Therapeutics Inc. Director Stock Option (Right to Buy) 90,000 09 Jun 2022 Direct

Insider Reports Filed by Simos Simeonidis

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RGLS Regulus Therapeutics Inc. 09 Jun 2022 1 $0 4 Director 10 Jun 2022, 16:16
RGLS Regulus Therapeutics Inc. 14 Jun 2021 1 $0 4 Director 15 Jun 2021, 17:17